QuDoS

Views & Analysis

Case study: Ensuring safety by digitally linking prescriptio...

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.

Views & Analysis

‘Listen to your patients’: the best MS care honoured at QuDo...

Best healthcare professionals working in multiple sclerosis (MS) honoured QuDoS awards.

News

NHS "isn't delivering equitable care for rare diseases"

A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks